Search clinical trials for: Inulin

Total 2832 results

GlaxoSmithKline

Completed

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

Diabetes Mellitus, Type 2

United States, Germany, Taiwan, South Africa, Korea, Republic of, Spain, Brazil, India, Peru, Philippines, United Kingdom, Hong Kong, France, Mexico
Universidade de Passo Fundo
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Completed

Inulin and S. Salivarius Reduce Halitosis

Halitosis | Tongue Diseases
Université NAZI BONI
Juvenile Diabetes Research Foundation; International Society for Pediatric... and other collaborators

Recruiting

Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin

Type 1 Diabetes

Burkina Faso
Michigan State University

Completed

Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

Exercise | Insulin

United States
Massachusetts General Hospital
Boston University

Terminated

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Type 1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

Local Registration Trial in China Humalog Mix 50

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

China, Argentina, Mexico
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

China, Mexico, Argentina
Dance Biopharm Inc.

Completed

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes (Samba-01)

Type 1 Diabetes Mellitus
Sanofi

Completed

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin

Type 1 Diabetes Mellitus

United States
Northumbria University
Diabetes UK

Completed

Post-exercise Insulin Reductions in Type 1 Diabetes

Type 1 Diabetes

United Kingdom
Elaine Chow
Sanofi

Completed

Toujeo Versus NPH Self-titration Study

Diabetes Mellitus, Type 2

Hong Kong
Nanjing First Hospital, Nanjing Medical University

Recruiting

The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies

Diabetes

China
Bayer

Completed

To Evaluate Clinical Outcome and Injection Compliance of Scilin (SEAS)

Diabetes Mellitus, Type 2

China
Sanofi

Completed

Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus (EDITION JP II)

Type 2 Diabetes Mellitus

Japan
Medical University of Graz

Completed

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial (ENM-HS-001)

Diabetes, Type I

Austria
Kaplan Medical Center

Completed

Prebiotics in Patients With Non-alcoholic Liver Disease

Metabolic Syndrome | Non-alcoholic Fatty Liver Disease

Israel
Johns Hopkins University

Terminated

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
Loyola University
Sanofi

Completed

Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency

Renal Insufficiency | Type 2 Diabetes

United States
Adocia

Completed

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Sanofi

Completed

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

Diabetes Mellitus

United States
Consorci Sanitari Integral

Completed

Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes

Type 2 Diabetes Treated With Insulin
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) (DPT-1)

Diabetes Mellitus, Type 1

United States, Canada
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects

Clamp Study

Russian Federation
University of Alabama at Birmingham

Completed

Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM

Type 1 Diabetes Mellitus

United States
M.D. Anderson Cancer Center
Novo Nordisk A/S

Terminated

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

Lymphoma | Leukemia

United States
Novo Nordisk A/S

Completed

A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects

Healthy | Diabetes

Germany
Policlinico Hospital

Completed

Tight Glycemic Control and Insulin Administration During Parenteral Nutrition

Critical Ill Patient Undergone Parenteral Nutrition

Italy
Novo Nordisk A/S

Completed

A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics

Diabetes | Diabetes Mellitus, Type 1

Germany
Rush University Medical Center

Completed

Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin

Diabetes

United States
Hygieia, Inc
TKL Research, Inc.

Completed

Efficacy and Safety of Frequently Modified Intensive Insulin

Diabetes

United States
IKFE Institute for Clinical Research and Development

Completed

Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

Diabetes Mellitus

Germany
Karolinska Institutet

Completed

Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)

Type 2 Diabetes Mellitus | Postprandial Hyperglycemia

Sweden
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes (PRONTO-T1D)

Type 1 Diabetes Mellitus

Italy, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
Indonesia University

Completed

Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus

Indonesia
Pfizer

Completed

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

Diabetes Mellitus, Type 2

Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
Sanofi

Completed

Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Japan
Halozyme Therapeutics

Completed

Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

United States
Universiti Kebangsaan Malaysia Medical Centre

Recruiting

Effects of Topical Insulin on Levels of Tear Inflammatory Mediators

Dry Eye

Malaysia
Novo Nordisk A/S

Completed

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes (BEGIN™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Canada, South Africa, Romania, Brazil, China, Ukraine
Novo Nordisk A/S

Completed

A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
National Taiwan University Hospital
Chang Gung Memorial Hospital; Taipei Medical University Shuang Ho Hospital

Unknown

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke (ICAS)

Hyperglycemia | Acute Stroke

Taiwan
University Hospital, Caen

Completed

Medical ICU Paper-based Dynamic Insulin Protocol

Stress Hyperglycemia
Eli Lilly and Company

Withdrawn

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Washington University School of Medicine

Terminated

Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes

Type 1 Diabetes | Hyperglycemia, Postprandial

United States
Novo Nordisk A/S

Completed

A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Ain Shams University

Unknown

Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.

Type 1 Diabetes Mellitus With Hypoglycemia | type1diabetes

Egypt
Biocon Limited

Completed

Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients

Type2 Diabetes Mellitus

India
Eli Lilly and Company
Alkermes, Inc.

Completed

Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany, Italy, Puerto Rico, Hungary, Mexico, United States, India, Portugal, Taiwan, Brazil, Poland
Winthrop University Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital

Hyperglycemia | Diabetes Mellitus, Type 2

United States

3

Subscribe